TScan Therapeutics, Inc.TCRXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-1287.62%
Near historical average
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-1301.99%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -1287.62% | +69.7% |
| 2024 | -4252.06% | -1017.4% |
| 2023 | -380.53% | +14.0% |
| 2022 | -442.62% | +0.9% |
| 2021 | -446.67% | +80.6% |
| 2020 | -2304.42% | - |
| 2019 | 0.00% | - |